Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Prepaid Assets (2023 - 2025)

WORK Medical Technology (WOK) posted Prepaid Assets of $41926.0 for Q3 2025, down 80.41% on a QoQ basis from $213994.0 in Q1 2025, and down 70.8% year-over-year from $143604.0 in Q3 2024.

WORK Medical Technology (WOK) has 3 years of Prepaid Assets data on file, last reported at $41926.0 in Q3 2025.

  • In Q3 2025, Prepaid Assets fell 70.8% year-over-year to $41926.0; the TTM figure through Sep 2025 stood at $41926.0 (down 70.8% YoY), while the FY2025 annual figure was $41926.0, down 70.8% from the prior year.
  • Prepaid Assets fell to $41926.0 in Q3 2025, from $213994.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $213994.0 in Q1 2025 and bottomed at $41926.0 in Q3 2025.
  • A 3-year average of $114764.8 and a median of $101569.5 in 2023 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets jumped 141.21% — and 2025, when it plunged 70.8%.
  • Year by year, Prepaid Assets stood at $59535.0 in 2023, then jumped by 141.21% to $143604.0 in 2024, then plunged by 70.8% to $41926.0 in 2025.
  • The last three Prepaid Assets figures came in at $41926.0 (Q3 2025), $213994.0 (Q1 2025), and $143604.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 WORK Medical Technology - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 41,926.00
Mar 31, 2025 213,994.00
Sep 30, 2024 143,604.00
Sep 30, 2023 59,535.00